Allogene Therapeutics (NASDAQ:ALLO) Price Target Raised to $8.00 at Citizens Jmp

Chronological Source Flow
Back

AI Fusion Summary

Citizens Jmp raised Allogene Therapeutics’ target to $8.00. Canaccord Genuity reiterated a buy with a $14.00 target. UBS, Argus, Robert W. Baird, Truist, and Sanford C. Bernstein also adjusted ratings and targets, ranging from $1.60 to $9.00.
#ALLOGENE_THERAPEUTICS #CITI_JMP #CANACCORD_GENUITY #UBS_GROUP #ARGUS #ROBERT_W_BAIRD #TRUIST_FINANCIAL #SANFORD_C_BERNSTEIN
15/04 11:38 defenseworld.net
3 Πηγές

Allogene Therapeutics (NASDAQ:ALLO) Price Target Raised to $8.00 at Citizens Jmp

COMPANIESPOLITICSANALYST ARTICLES - US
15/04 12:58 defenseworld.net

Allogene Therapeutics (NASDAQ:ALLO) Given New $3.85 Price Target at Argus

POLITICSANALYST ARTICLES - USCOMPANIES
15/04 14:32 defenseworld.net

Netflix (NASDAQ:NFLX) Price Target Raised to $120.00 at Moffett Nathanson

POLITICSCOMPANIESANALYST ARTICLES - US
Comments
Loading...
0